Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and S-1 in Metastatic or Recurrent HNSCC
NCT00805012Phase 2Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in head and neck squamous cell carcinoma (HNSCC), sponsored by Seoul National University Hospital. Started Dec 2008; status: terminated.
02
Drugs
tegafur
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00805012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805012.